Skip to content
This GLP
By This GLP Editorial Team · Updated September 2026Four terms, four lines, no dose

TelePeptide review

Every line publishes a month-to-month figure and three commitment rates, each stated as covering the evaluation, the prescription, the medication and the shipping — and no figure anywhere states a dose.

The verdict

TelePeptide publishes sixteen figures across four lines, opening at $199 a month for injected semaglutide bought a month at a time and falling to $169 on an annual commitment. Every tier is stated as all-inclusive.

Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.

Category
GLP-1 telehealth
Molecule
Semaglutide · Tirzepatide
Form
Injection · Oral
Injection
From $199/mo
Oral
From $229/mo
Prescription
Required
Compounded
Yes — not FDA-approved

TelePeptide sells both molecules as an injection and as a dissolvable sublingual tablet, and prices each of those four lines at four different commitment lengths, so a buyer meets sixteen published figures where a single starting price would normally stand.

  1. Who writes the prescription, and what do they see?

    The physician evaluation is named as part of what each figure covers, which is a more specific claim than the usual promise that a prescription will be issued, though no individual clinician is described anywhere on the pages read.

    Stating plainly that a figure already contains the evaluation, the prescription, the medication and the shipping removes the four charges that most commonly appear after a purchase, and it is why this seller carries no fee correction on this site.

  2. What happens when the dose goes up?

    Nothing in sixteen published figures says what happens when a dose goes up, and on a sublingual formulation the silence matters more than usual, because a reader cannot even infer the answer from a pen strength they can see.

  3. What the price includes

    Injected semaglutide is $199 month to month, $189 on three months, $179 on six and $169 on an annual prepay, so a year at the monthly rate costs $360 more than the same year committed in advance. The dissolvable semaglutide tablet runs $229, $219, $209 and $199, injected tirzepatide $249, $237, $224 and $214, and the tirzepatide tablet $249, $239, $229 and $219. Month to month the two tirzepatide formats cost the same, and at every other term the tablet costs more than the injection of the same molecule.

  4. What it claims, and what it cites

    All four lines are compounded, prepared by a pharmacy the site does not name, and the FDA reviews none of them before dispensing — a caveat with particular force for a sublingual tablet, a format no approved product comes in.

Where it holds up, and where it does not

  • Strength: Four commitment lengths published on every line
  • Strength: Each tier stated as covering evaluation, prescription, medication and shipping
  • Strength: The month-to-month option is priced rather than withheld
  • Strength: Both molecules available in both formats
  • Limitation: No milligram dose appears beside any of the sixteen figures
  • Limitation: The annual rate requires a year committed in advance
  • Limitation: The tablets never cost less than the injections
  • Limitation: No compounding pharmacy is named

What the evidence says about this kind of treatment

The assessment above is about TelePeptide. These are about the drugs it sells, and they are traced to the primary literature.

Right for
A reader who wants the whole commitment ladder priced in advance and is content to ask about dose separately.
Wrong for
A reader who needs to know what any of these sixteen figures becomes once the dose starts climbing.

The evidence behind what TelePeptide prescribes

These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation.

How TelePeptide compares

SellerWho it suitsGo
Midi HealthReaders who want every rung costed, with its milligram, before choosing a first doseSee Midi Health →
PeptiReaders who want labs and physician care inside one figure and count fills rather than monthsSee Pepti →
ShedRxReaders willing to telephone a seller and ask which published fee is the real oneSee ShedRx →
Compare all providers side by side →

More GLP-1 telehealth sellers reviews: Strut HealthWellorithmWillowYourEraEverPrimeMyDrHank

Sponsored alternative

SkinnyRx

Readers choosing tirzepatide, the one line with a published standing rate

Check SkinnyRx availability →

Frequently asked

What does all-inclusive mean here?
The seller states that each tier covers the physician evaluation, the prescription, the medication and the shipping, which is why this site applies no fee correction to any of its figures.
What does committing to a year save?
On injected semaglutide it is $30 a month against the month-to-month rate, or $360 over the year that the commitment lasts.
Is the tablet cheaper than the injection?
No. The sublingual semaglutide tablet runs $30 a month above the injection at every term. The two tirzepatide formats cost the same month to month, and the tablet costs more on every commitment.
Is TelePeptide expensive compared with other GLP-1 telehealth sellers?
TelePeptide publishes a starting figure of $199/mo. Across the 402 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $49 to $525.42 with a median of $190, which puts TelePeptide above the median. The other 178 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.
This GLP Editorial TeamPublisher · Updated September 2026

How this was assessed. The four questions above are answered from TelePeptide’s own publicly-stated model, against the published editorial methodology. No ratings are fabricated and no first-hand outcomes are claimed. A partnership never changes the assessment — see how we make money.